Related Experiment Video
Updated: Jun 2, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Outcomes after heart transplantation in children under six years of age
Ari R Joffe1, Luis G Quiñonez, Charlene M T Robertson
1Department of Pediatrics, School of Public Health, John Dossetor Health Ethics Center, University of Alberta, and Stollery Children's Hospital, Edmonton, Alberta, Canada. ari.joffe@albertahealthservices.ca
Insights
Pediatric heart transplant recipients often experience developmental delays, especially those with congenital heart disease (CHD). Early intervention and close follow-up are crucial for improving outcomes in these young survivors.
Area of Science:
- Pediatric Cardiology
- Developmental Pediatrics
- Transplant Medicine
Background:
- Improved survival rates post-pediatric heart transplant necessitate focus on developmental outcomes.
- Assessing neurodevelopmental trajectories in young heart transplant recipients is critical.
Purpose of the Study:
- To determine survival, morbidity, and developmental outcomes in children under six undergoing heart transplant.
- To identify predictors of neurodevelopmental outcomes in this cohort.
Main Methods:
- Inception cohort study of 33 children under six undergoing heart transplant (1999-2006).
- Collected pretransplant, transplant, and posttransplant data.
- Used univariate and multiple regression analyses for neurodevelopmental outcomes at least 12 months posttransplant.
Main Results:
- 12% mortality; survivors frequently exhibited low weight (28%) and height (31%).
- High rates of language (41%), motor (52%), mental (34%), and adaptive (48%) delays observed.
- Congenital heart disease (CHD) was significantly associated with death-disability-mental delay (OR 7.94, p=0.011) and mental/language delay.
Conclusions:
- Adverse neurodevelopmental outcomes are common in pediatric heart transplant survivors, particularly those with CHD.
- Pre- and post-transplant counseling and early intervention are essential for high-risk children.
Background:
Survival after heart transplant has improved and more attention is focused on developmental outcomes. We aimed to determine the survival, morbidity, and developmental outcomes of young children after heart transplant.
Methods:
All children under 6 years of age having a heart transplant in Edmonton between 1999 and 2006 were included in this inception cohort study. Demographics, pretransplant, transplant, and posttransplant variables were collected. The association of potentially predictive variables with neurodevelopmental outcomes at least 12 months posttransplant were determined by univariate and multiple regression analyses.
Results:
Thirty-three children had a heart transplant; 18 with congenital heart disease (CHD) and 15 with cardiomyopathy-myocarditis (non-CHD). Mortality during 19 (8) months of follow-up was 12% (95% confidence interval [CI] 3% to 28%). Survivors had frequent low weight (28%) and height (31%), and delay in language (41%), motor (52%), mental (34%), and general adaptive composite (48%) scores. Only CHD was associated with death-disability-mental delay on multiple regression (odds ratio 7.94; 95% CI 1.6 to 39.4, p=0.011). The CHD was also associated with mental and language delay on multiple regressions. Mental delay occurred in 8 (53%) with CHD and 2 (14%) with non-CHD (p=0.05). Mental score of 85 or greater was found in 13.4% of patients with CHD compared with 50% with non-CHD (p=0.05).
Conclusions:
In this single-center inception cohort study, adverse neurodevelopmental outcomes in survivors of heart transplant before the age 6 years were common, particularly in those with CHD. Careful pretransplant and posttransplant counseling are needed, and close follow-up with early intervention for these high-risk children is imperative.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Heart Failure VI: Adjunct Therapies

